Dupin, N. and Giudice, D.P. (2008) Treatment of kaposi sarcoma in the highly active antiretroviral therapy era. Clinical Infectious Diseases, 47, 418-420. doi:10.1086/589866

has been cited by the following article:

• TITLE: Maxillofacial sarcomas: a ugandan epidemiological survey

  AUTHORS: Kamulegeya Adriane

  KEYWORDS: Maxillofacial Sarcomas, Kaposi’s Sarcoma, Maxillofacial Tumors, Head and Neck Tumors

  JOURNAL NAME: Open Journal of Stomatology, Vol.1 No.2, July 1, 2011

  ABSTRACT: We reviewed the case notes of 203 patients who were treated for sarcomas of the oral and maxillofacial region over a period of 5 years. There were 98 male cases (mean age 31.4 ± 12.8 years) and 105 female cases (mean age 29.3 ± 10.4). Kaposi’s sarcoma accounted for 82.8% cases, and rhabdomyosarcoma 6.9% followed by osteosarcoma and chondrosarcoma at 2.5% each. Except for Kaposi’s sarcoma, surgery in combination with radiotherapy and/or chemothe- rapy was the main stay of treatment. Survival data was not available for most of our patients.